Latest news with #ArticlesofIncorporation
Miami Herald
12-06-2025
- Business
- Miami Herald
Amaze Announces Annual Stockholders' Meeting Results and 1-for-23 Reverse Stock Split
NEWPORT BEACH, CA / ACCESS Newswire / June 12, 2025 / Amaze Holdings, Inc. (NYSE American:AMZE) ("Amaze" or the "Company"),a global leader in creator-powered commerce, today announced the results of its annual stockholders' meeting held today. Election of Directors: Stockholders elected all seven director nominees to serve until the 2026 Annual Meeting of of Auditors: Stockholders ratified the appointment of Wipfli LLP as the Company's independent registered public accounting firm for the fiscal year D Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of the Company's Series D Convertible Preferred Stock and the exercise of associated warrants, exceeding the "Exchange Share Cap" and "Individual Holder Share Cap" limitations, as provided in the Series D Certificate of Designation. This approval also authorizes a change of control under applicable NYSE American Stock Split Proposal: Stockholders approved the authorization of a reverse stock split of the Company's common stock at a ratio between 1-for-10 and A Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series A Convertible Preferred Stock in excess of the applicable share caps under the Certificate of Designation and NYSE American B Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series B Convertible Preferred Stock in excess of the applicable share C Preferred Stock Conversion Proposal: Stockholders approved the issuance of common stock upon conversion of Series C Convertible Preferred Stock in excess of the applicable share Common Stock Increase Proposal: Stockholders did not approve an amendment to the Company's Articles of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 250,000, Plan Amendment Proposal: Stockholders approved an amendment and restatement of the 2021 Equity Incentive Plan to increase the number of shares available for issuance to 20,800,000 shares (prior to the effect of the reverse stock split).ELOC Issuance Proposal: Stockholders approved the issuance of 20% or more of the Company's issued and outstanding common stock in connection with the securities purchase agreement dated May 6, Proposal: Stockholders approved the proposal to adjourn the annual meeting, if necessary, to solicit additional proxies. For more information please refer to the Company's proxy statement filed with the United States Securities and Exchange Commission (SEC) on May 7, 2025. Reverse Stock Split Amaze also announced today that it will effect a 1-for-23 reverse stock split at 5:00 p.m. Eastern time today. Beginning with the opening of trading on June 13, 2025, Amaze's common stock will trade on a split adjusted basis under the new CUSIP number 35804X 200. The final 1-for-23 ratio was determined by Amaze's Board of Directors on June 2, 2025, and the reverse stock split was effected by filing a Certificate of Amendment to Amaze's articles of incorporation on June 12, 2025 with the Secretary of State of the State of Nevada. The reverse stock split is intended to increase the per share market price of Amaze's common stock to meet the $3.00 per share minimum bid price requirement of the NYSE American. Additional details regarding the reverse stock split can be found in the Current Report on Form 8-K filed on June 12, 2025 with the SEC as well as the Company's proxy statement. For investor information, visit IR@ For press inquiries, please contact PR@ About Amaze:Amaze Holdings, Inc. is an end-to-end, creator-powered commerce platform offering tools for seamless product creation, advanced e-commerce solutions, and scalable managed services. By empowering anyone to "sell anything, anywhere," Amaze enables creators to tell their stories, cultivate deeper audience connections, and generate sustainable income through shoppable, authentic experiences. Discover more at Cautionary Note Regarding Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements relate to future events and developments or to our future operating or financial performance, are subject to risks and uncertainties and are based estimates and assumptions. Forward-looking statements may include, but are not limited to, statements about the reverse stock split, our market opportunity and potential growth of that market, strategies, initiatives, growth, revenues, expenditures, our plans and objectives for future operations, and future financial and business performance. These statements can be identified by words such as such as "may," "might," "should," "would," "could," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or "continue," and are based our current expectations and views concerning future events and developments and their potential effects on us. These statements are subject to known and unknown risks, uncertainties and assumptions that could cause actual results to differ materially from those projected or otherwise implied by the forward-looking statement. These risks include: our ability to execute our plans and strategies; our limited operating history and history of losses; our financial position and need for additional capital; our ability to attract and retain our creator base and expand the range of products available for sale; we may experience difficulties in managing our growth and expenses; we may not keep pace with technological advances; there may be undetected errors or defects in our software or issues related to data computing, processing or storage; our reliance on third parties to provide key services for our business, including cloud hosting, marketing platforms, payment providers and network providers; failure to maintain or enhance our brand; our ability to protect our intellectual property; significant interruptions, delays or outages in services from our platform; significant data breach or disruption of the information technology systems or networks and cyberattacks; risks associated with international operations; general economic and competitive factors affecting our business generally; changes in laws and regulations, including those related to privacy, online liability, consumer protection, and financial services; our dependence on senior management and other key personnel; and our ability to attract, retain and motivate qualified personnel and senior management. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other future filings and reports that we file with the Securities and Exchange Commission (SEC) from time to time. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the press release. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments. SOURCE: Amaze Holdings, Inc.
Yahoo
11-06-2025
- Business
- Yahoo
Voting Cards Reveal that Over 50% of Shareholders Excluding the Founding Family and Related Parties Voted For Oasis's EGM Proposals and Against Mr. Akihiro Kobayashi's Renomination at the AGM
(Securities Code: 4967 JT) *Oasis's proposals at the EGM had over majority approval, when calculated on the basis of excluding the shares owned by the founding family and its related parties (Majority of Minority, "MoM") *The Special Resolution (Agenda 1) at the AGM, which called for amendments to Kobayashi Pharma's Articles of Incorporation, received supermajority approval, which is more than two-thirds of affirmative votes out of all voting rights exercised at AGM ("Supermajority of Minority") *Additionally, over majority of voting rights at the AGM went against Mr. Akihiro Kobayashi's reappointment when calculated on MoM basis More information available at HONG KONG, June 11, 2025--(BUSINESS WIRE)--Oasis Management Company Ltd. ("Oasis") is the manager to funds that beneficially own over 10.1% of Japanese pharmaceuticals and food products manufacturer Kobayashi Pharmaceutical Co., Ltd. (4967 JT) ("Kobayashi Pharma" or the "Company"). As Kobayashi Pharma's second largest shareholder and the largest institutional shareholder, Oasis has accelerated its efforts to rebuild the Company's governance in order to secure appropriate reparations for the victims of the Beni Koji scandal, and to ensure improved product safety going forward. As part of its efforts, Oasis called for an extraordinary general shareholders' meeting ("EGM"), held a campaign at the annual general shareholders' meeting ("AGM", and together with the EGM, the "GMs"), and initiated a shareholder derivative lawsuit against its current and former board of directors (including outside directors). We are thankful for all the support of minority shareholders at the GMs. As part of our continued efforts to improve Kobayashi Pharma's corporate governance, we requested that the Company allow us to inspect the submitted voting cards for the GMs and count the voting rights exercised by the founding family and its related parties. From this inspection, Oasis discovered that the Kobayashi family and its related parties (individuals and entities that can reasonably be presumed to have long-standing close relationships with the Kobayashi family; the Kobayashi family together with such related parties collectively, the "Founding Family Related Parties") prevented improvement of Kobayashi Pharma's corporate governance by voting against, or abstaining from voting for, the amendments to its articles of incorporation (Special Resolution (Agenda 1)). The amendments were proposed by Kobayashi Pharma itself, in order to break away from its dependence on the Kobayashi family and improve its corporate governance. Given the above, in order to reveal the general shareholders' "true will" which has not been affected by the Kobayashi family's intent, we recalculated the number of exercised voting rights, excluding those of the Founding Family Related Parties who voted against the Company's proposal for improvement of corporate governance. As a result, on MoM basis, we found that Oasis's proposals at the EGM all received over 50% of approval. We also confirmed that the proposal for amendments to Kobayashi Pharma's Articles of Incorporation received Supermajority (i.e., more than two-thirds majority) support on MoM basis, and that the majority of all exercised voting rights were against Mr. Akihiro Kobayashi's reappointment at the AGM. Please see the accompanying graphs, "Voting at EGM" and "Voting at AGM". Oasis will continue to explore all possible options to prevent the recurrence of the Beni-Koji scandal and to improve corporate governance by breaking the Company's dependence on its founding family. Additionally, Oasis strongly requests that, taking into account the Founding Family Related Parties' exercise of voting rights (i.e., opposition to amendments of articles of incorporation for the purpose of improving corporate governance), Kobayashi Pharma require Mr. Kazumasa Kobayashi and Mr. Akihiro Kobayashi to resign from their roles as Special Advisor and Director in charge of compensation, respectively. To learn more please visit We welcome all stakeholders to contact Oasis at info@ to help improve Kobayashi Pharma's corporate governance and, thus, ensure consumer safety. *** Oasis Management Company Ltd. manages private investment funds focused on opportunities in a wide array of asset classes across countries and sectors. Oasis was founded in 2002 by Seth H. Fischer, who leads the firm as its Chief Investment Officer. More information about Oasis is available at Oasis has adopted the Japan FSA's "Principles of Responsible Institutional Investors" (a/k/a the Japan Stewardship Code) and, in line with those principles, Oasis monitors and engages with our investee companies. The information and opinion contained in this press release (referred to as the "Document") is provided by Oasis Management Company ("Oasis") for informational purposes only or for reference purposes only. The Document is not intended to solicit or seek shareholders to, jointly with Oasis, acquire or transfer, or exercise any voting rights or other shareholder's rights with respect to any shares or other securities of a specific company which are subject to the disclosure requirements under the large shareholding disclosure rules under the Financial Instrument and Exchange Act ("FIEA"). Shareholders that have an agreement to jointly acquire or transfer, or exercise their voting rights or other shareholder's rights with respect to any shares or other securities of a specific company are regarded as Joint Holders under the Japanese large shareholding disclosure rules and they must file notification of their aggregate shareholding with the relevant Japanese authority for public disclosure under the Financial Instruments and Exchange Act. Except for the case where Oasis expressly enters into such agreement, Oasis does not intend to be treated as a Joint Holder and/or a Specially Related Person with other shareholders under the Japanese FIEA or to take any action triggering reporting obligations as a Joint Holder. Oasis does not have any intention to receive any power to represent other shareholders in relation to the exercise of their voting rights. The Document exclusively represents the opinions, interpretations, and estimates of Oasis. View source version on Contacts For all inquiries, please contact:Taylor Hallmedia@ Sign in to access your portfolio
Business Wire
11-06-2025
- Business
- Business Wire
Odyssey Marine Exploration Advances Mexico Fertilizer Project With JV Formation and Provides Corporate Updates
TAMPA, Fla.--(BUSINESS WIRE)--Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), an ocean exploration pioneer engaged in the discovery, development, and extraction of strategic minerals that provide solutions to global challenges, today announced that it has completed the first of several key steps in the advancement of its previously disclosed joint venture with Capital Latinoamericano ('CapLat'). 'This progress comes at a time of heightened global focus on strategic minerals, including phosphate for fertilizers,' said Mark Gordon, Chairman and CEO of Odyssey. The joint venture, formally named PHOSAGMEX, aims to establish a domestic fertilizer supply that enhances North American food security and supports sustainable agricultural practices. As part of this effort, an Odyssey subsidiary has initiated the transfer of legal rights to certain mining concessions to the joint venture. 'This progress comes at a time of heightened global focus on strategic minerals, including phosphate for fertilizers,' said Mark Gordon, Chairman and CEO of Odyssey. 'Transferring project rights at this stage is a critical step in ensuring the success of the PHOSAGMEX initiative. We are pleased to be working with CapLat, led by Juan Cortina Gallardo, and believe this partnership gives the project its greatest chance of success. Juan brings invaluable leadership to PHOSAGMEX through his experience as former President of Mexico's National Agricultural Council (Consejo Nacional Agropecuario), which represents over 80% of the country's agri-food GDP, and his leadership at Siembra, CIMMYT, Santander Mexico, and Rabobank's International Advisory Council.' As Odyssey advances operational milestones, such as the PHOSAGMEX partnership, the company also remains focused on aligning its corporate structure and governance to support long-term growth. On June 9, 2025, Odyssey held its annual meeting of stockholders where stockholders voted on several proposals by the company, including election of directors, ratification of Grant Thornton LLP as the Company's independent public accounting firm, and an advisory 'say on pay' approval of compensation of Odyssey's named executive officers. Although more than 80% of stockholders who voted approved the proposed amendment of the company's Articles of Incorporation, including a proposed increase in the number of authorized shares of common stock and a reverse stock split, the proposals did not receive the requisite approval of a majority of the voting power of the Company as required by Nevada law. Both proposals were intended to provide further flexibility for the company; the inability to implement them does not affect Odyssey's ability to meet its needs and execute its strategy. Odyssey CEO and Chairman Mark Gordon will present at the Emerging Growth Conference on June 17, 2025, at 2:55 PM EST. Mr. Gordon will highlight upcoming project catalysts, including those for PHOSAGMEX, and outline the company's long-term strategy for value creation. Interested individual and institutional investors, analysts, and advisors are invited to register to attend live or gain access to the archived webcast. A replay of the presentation will be available on and the Emerging Growth YouTube Channel after the event. About Odyssey Marine Exploration Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) is a global leader in ocean exploration with over 30 years of experience. The company is committed to the sustainable and responsible discovery, validation, and advancement of seafloor critical mineral projects, including polymetallic nodules for battery metals and subsea phosphate deposits for fertilizers. Offering comprehensive research, marine operations, and regulatory compliance support, Odyssey works with governments and seafloor rights holders worldwide. Odyssey develops its projects in collaboration with a global network of partners, academics, and industry professionals who share its commitment to environmentally sound solutions for obtaining minerals that address present and future global challenges. Learn more at Forward Looking Information Odyssey Marine Exploration believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Part I, Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on March 31, 2025. The financial and operating projections as well as estimates of mining assets are based solely on the assumptions developed by Odyssey that it believes are reasonable based upon information available to Odyssey as of the date of this release. All projections and estimates are subject to material uncertainties and should not be viewed as a prediction or an assurance of actual future performance. The validity and accuracy of Odyssey's projections will depend upon unpredictable future events, many of which are beyond Odyssey's control and, accordingly, no assurance can be given that Odyssey's assumptions will prove true or that its projected results will be achieved.
Business Wire
11-06-2025
- Business
- Business Wire
Hibiki Path Advisors Finalized Its Policy to Oppose ① the Proposed Transition to a Company With an Audit and Supervisory Committee and ② the Election of Certain Director Candidates for the 54 th Annual General Meeting of JAPAN PURE CHEMICAL CO., LTD.
TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors ('we' or 'us') has decided its policy on (Item 1) the proposed transition to a company with an Audit and Supervisory Committee through an amendment of Articles of Incorporation and (Items 2, 3 and 4) the election of directors, in relation to the 54th Annual General Meeting of Shareholders ('AGM') of JAPAN PURE CHEMICAL CO., LTD. (TSE Code: 4973) ('the Company', 'JPC'), scheduled on June 20, 2025. We outlined our policy as a "plan" in the statement of purpose on June 1 (hereinafter, the "Statement"). Since then, we have made persistent and good-faith efforts to engage with JPC. However, due to JPC's continued inaction and lack of meaningful response following the publication of the Statement, we hereby formally confirm that our policy has now been finalized, fully consistent with the content in the Statement. For the detailed rationale behind our planned policy on each proposal in the Statement— please refer to the Statement at the following link: " Regarding the Campaign as the largest Shareholder of JAPAN PURE CHEMICAL CO., LTD." First, we oppose (Item 1) the proposed transition to a company with an Audit and Supervisory Committee through an amendment of Articles of Incorporation. We have serious concern that the transition to a company with an Audit and Supervisory Committee is purely ceremonial, given that the outside directors are predominantly composed of individuals from a specific corporate group, making meaningful oversight unlikely. Furthermore, the proposed expansion to a ten-member Board, representing nearly 20% of the Company's total workforce, will not only risk further slowing down the decision-making process, but also unintentionally lead to a deterioration in the overall corporate governance quality. We are deeply concerned that this transition would effectively grant even greater authority over critical business execution to the current internal executive team despite their ongoing failure to implement fundamental reforms to resolve key management issues. Furthermore, by diluting important authority such as the individual right to conduct audits, the proposal would further erode the effectiveness of auditors (Members of the Audit and Supervisory Committee). As JPC's sole largest shareholder, we find this proposal unacceptable. While our opinion differs from that of Institutional Shareholder Services ('ISS'), it is important to recognize that ISS's analysis is based on uniform, standardized criteria. In our view, given the specific issues surrounding JPC, the proposed transition will not necessarily result in the governance improvements that are expected in more general circumstances. We strongly encourage all shareholders to read our recent Statement related to ISS recommendations carefully and to make a considered, independent decision (7/Jun/2025 – ISS Endorses Hibiki's Shareholder Proposals to JAPAN PURE CHEMICAL CO., LTD.). Second, with respect to (Items 2, 3, and 4) the election of directors, we declare our support exclusively for the reappointment of President and Representative Director Tomoyuki Kojima (Item 2.1) and Outside Director Momoe Kuromatsu (Item 2.6). We oppose the appointments of all other Directors (Items 2, 3, and 4) (including alternates), especially the reappointment of Director and Honorary Advisor Masao Watanabe (Item 2.3). Our rationale is summarized in Figure 1 below. Figure 1: List of the candidate of directors etc. Although our view differs from the ISS's recommendation, our voting decisions on each candidate are determined independently based on a thorough assessment of the Company after years of direct engagement. We strongly believe that the responsibility for the 'capital misallocation' cited by ISS for opposing the reappointment of President and Representative Director Tomoyuki Kojima actually lies with Director and Honorary Advisor Masao Watanabe instead as he had led JPC as a Representative Director for more than 20 years but completely failed to address this issue. In our view, it is essential that Director and Honorary Advisor Watanabe, who has held a dominant leadership position for approximately 25 years to step down from the Board for JPC to undertake bold reforms and enhance corporate value. At the same time, we believe that the structure of the Board of Directors, which has long been composed of members continuously appointed from a limited group of backgrounds, must be fundamentally restructured. Based on the same logic mentioned above, we hereby firmly make it clear that fundamental capital allocation reforms 'within his one-year term' to be our definitive condition in supporting Representative Director Tomoyuki Kojima's re-election for another year. If only the two Directors for whom we supported reappointment are elected at this AGM, JPC will no longer meet the statutory minimum number of Directors required under the Companies Act for a company with a Board of Directors. In that case, as the largest shareholder engaging JPC for many years, we express our strong commitment to collaborate closely with President and Representative Director Tomoyuki Kojima and Outside Director Momoe Kuromatsu to identify and endorse director candidates who will genuinely drive the enhancement of JPC's corporate value. We earnestly expect that such candidates will be proposed at the Extraordinary General Meeting of Shareholders. This is to establish a unified corporate structure where the management, shareholders, and employees are synergized to decisively address and overcome the significant challenges that the Company is currently facing. Lastly, as JPC's largest shareholder, we had earnestly requested the voluntary disclosure of the Board of Directors' rules and meeting minutes. We had also requested meetings with all director candidates individually (excluding alternates). We think this is essential for anyone to determine if the proposed transition to a company with an Audit and Supervisory Committee and the appointment of Directors make sense. However, these requests were flatly turned down, and instead the Company proposed a meeting with only three individuals (President and Representative Director Tomoyuki Kojima, Senior Director Motoki Watanabe, and Mr. Yasutoshi Ohata, Chair of the Nomination and Remuneration Committee) which was finally held on 5 th June 2025. In the meeting, we asked focused questions to the three individuals and have thoughtfully assessed their answers internally. However, we have reached the conclusion that the aforementioned fundamental concerns and risks remain unaddressed, as they failed to provide satisfactory explanations regarding the essential rationale for increasing the number of directors while retaining all existing directors and auditors, as well as the necessity and timing of the transition to the Audit and Supervisory Committee system. Once again, we respectfully urge all shareholders to consider supporting our proposals (Items 10, 11, 12, and 13) which are directed to enhancing and maximizing the collective interests of all shareholders. We also request that you as a valuable shareholder exercise shareholder rights (voting rights) for (Item1) amendments to the Articles of Incorporation for the transition to a company with an Audit and Supervisory Committee, and (Items 2, 3, and 4) the election of directors, together with our shareholder proposals, based on your own careful and rational judgment in terms of whether these measures genuinely contribute to the enhancement of the Company's corporate value. As mentioned earlier, we have made it clear that fundamental capital allocation reforms 'within his one-year term' to be our condition in supporting Representative Director Tomoyuki Kojima's re-election for another year. Mr. Kojima should fully acknowledge the clear and persistent challenges concerning capital efficiency of JPC, as correctly pointed out by ISS based on its two consecutive years of endorsing our shareholder proposals related to the matter, and implement long awaited fundamental reforms in capital allocation, completely overwriting the time frame and level that is written in its medium-term plan. *At the time of this release, we remain committed to continuing our dialogue with the Company. Although the progress of discussions so far indicates that a change is unlikely, if any new information gained through ongoing engagement causes us to revise our decision, we will disclose the changes along with the reasons for them. Sincerely yours, Note: This post does not constitute a solicitation for an offer to acquire or recommend the purchase or sale of specific securities, or advice on investment, legal, tax, accounting, or any other matters. In the event of any discrepancy or conflict between the English and Japanese versions, unless otherwise noted, the meaning of the Japanese language version shall prevail unless otherwise expressly indicated.
Yahoo
11-06-2025
- Business
- Yahoo
Therma Bright Inc. Announces Share Consolidation
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma Bright" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces, subject to the approval of the TSX Venture Exchange (the "TSXV"), that it will be undertaking a consolidation (the "Consolidation") of its common shares on the basis of eight (8) pre-Consolidation common shares for one (1) post-Consolidation common share. The Company expects that the Consolidation will provide the Company with increased flexibility in structuring and completing financings and potential business transactions. No fractional common shares will be issued, and fractions of less than one-half of a share will be cancelled and fractions of at least one-half of a share will be converted to a whole common share. Outstanding options, warrants and other rights to acquire common shares will likewise be adjusted for the Consolidation. The Company currently has 451,632,147 common shares outstanding and accordingly expects 56,454,018 common shares to be outstanding on completion of the Consolidation (subject to rounding adjustments and any further share issuances prior to the Consolidation). The Company does not expect to change its name or trading symbol in conjunction with the Consolidation. The Consolidation has been approved by the Board of Directors pursuant to the Company's Articles of Incorporation, which empowers the Board to effect share consolidations of up to 10:1 without shareholder approval. The Company confirms that this is the only share consolidation conducted within the past 24 months and the cumulative consolidation ratio does not exceed 10:1, in compliance with TSXV Policy 5.8. About Therma Bright Inc. Therma Bright develops and partners on cutting-edge diagnostic and medical device technologies that address key healthcare challenges. Therma Bright Inc. trades on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: Therma Bright Fia, CEOrfia@ Follow us on X FORWARD-LOOKING STATEMENTS Certain statements in this news release constitute "forward-looking" statements. These statements relate to future events such as current and future development of Therma Bright's products and related technology as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether such results will be achieved. Actual results could differ materially from those anticipated due to several factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations. Completion of the Consolidation remains subject to all necessary corporate and regulatory approvals. If the required approvals are not obtained, the Consolidation may not proceed as contemplated or at all. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. To view the source version of this press release, please visit Sign in to access your portfolio
